Conventional Physiotherapy AFO and Electrical Stimulation in 5 years old Becker Muscular Dystrophy: Single Case Report

Authors

  • Karthikeyan T. Clinical Researcher, Physiotherapy Unit, NIMHANS (National Institute of Mental Health and Neurosciences), Bangalore, Karnataka, India

Keywords:

Duchenne Muscular Dystrophy, Electrical Stimulation, Handheld dynamometer, North Star Ambulatory Assessment, Physiotherapy

Abstract

Introduction: Becker muscular dystrophy (BMD) is an inherited condition that causes progressive weakness and wasting of the skeletal and cardiac (heart) muscles. It primarily affects males. The age of onset and rate of progression can vary. Muscle weakness usually becomes apparent between the ages of 5 and 15. Prevalence according to Indian Association of Muscular Dystrophy 30 cases per 1,00,000 in India. Case presentation: 8 years male had difficulty in walking and playing, difficulty in sit to stand, frequently respiratory infection, pain in calf region. Patient had started physiotherapy treatment with electrical stimulation for both lower limb muscles. Management and outcome: In exercise stretching exercise, strengthening exercise, breathing exercise, endurance training, electrical stimulation, functional mobility scale. Discussion: Post Exercise and electrical stimulation were improved in the lower Limb muscles strength for the lower limb function following intervention was observed in the child. Conclusion: Post Exercise and electrical stimulation were used for lower limb muscle strength and functional improvement. So, there was improved the lower limb muscle strength functional improvement was examined by FMS scale. Significant changes noted and seen improvement in daily activities living.

References

Emery AEH, Muntoni F. Duchenne muscular dystrophy. 3rd edition. Oxford: Oxford University Press; 2003.

Emery AEH. Population frequencies of inherited neuromuscular diseases a world survey. Neuromuscul Disord. 1991; 1 (1): 19–29.

Monaco AP, Bertelson CJ, Colletti-Feener C, et al. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet. 1987 Mar; 75 (3): 221–7.

Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Beckers Muscular Dystrophy locus. Cell. 1987; 51 (6): 919–928.

Duchenne muscular dystrophy: MedlinePlus Medical Encyclopedia". Nlm.nih.gov. Retrieved 2013-02-16. Available online at: https://medlineplus.gov/ency/article/000705.htm

Emery 1993; muscular dystrophy association, 2001. Available online at: https://www.ncbi.

nlm.nih.gov/books/NBK1436/

IAMD, Muscular dystrophy–rare disease in India. Available online at: http://www.rarediseases

india.org/musculardystrophy#:~:text=Muscular%20dystrophy%20(MD)%20is%20a,3500%20or%200.029%25)1.

Jones KJ, NOM KN. Recent advances in the diagnosis of the childhood muscular dystrophies. J Pediatric Child Health 1997; 33 (3): 195–201.

DMD Pathology Neuromuscular Disease Center.Jan S Tecklin. Pediatric physiotherapy, 4th ed. Pennsylvania: Lippincott, Williams & Wilkins; 2008.

Neurological rehabilitation, 5th edition, Darcy A Umphred, page no 515–520

James A Timmons. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. The FASEB Journal 2005; 19 (7): 750–760.

M Scott, VRBOVA. Responses of muscles of patients with Beckers Muscular Dystrophy to chronic electrical stimulation. Journal of Neurology, Neurosurgery, and Psychiatry1986; 49 (12): 1427–1434.

Serge S. Colson, PhD, Michal Benchortane. Neuromuscular Electrical Stimulation Training: A Safe and Effective Treatment for Fascioscapulohumoral Muscular Dystrophy Patients. Arch Phys Med Rehabil. 2010 May; 91 (5): 697–702.

Downloads

Published

2022-01-05

Issue

Vol. 11 No. 3 (2021)

Section

Short Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.